Plenvu and Skin - clammy - a phase IV clinical study of FDA data

Summary:

Skin - clammy is reported as a side effect among people who take Plenvu (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Calcium,.

The phase IV clinical study analyzes which people have Skin - clammy when taking Plenvu. It is created by eHealthMe based on reports of 742 people who have side effects when taking Plenvu from the FDA, and is updated regularly.

What is Plenvu?

Plenvu has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. eHealthMe is studying from 742 Plenvu users. Check the latest studies of Plenvu.

What is Skin - clammy?

Skin - clammy is found to be associated with 1,125 drugs and 1,709 conditions by eHealthMe. Check the latest studies of Skin - clammy.

On Jul, 17, 2026

742 people reported to have side effects when taking Plenvu.
Among them, 11 people (1.48%) have Skin - clammy.

Among these 11 people:

How long have people been on Plenvu when they have Skin - clammy? *

What is the gender of people who have Skin - clammy when taking Plenvu? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Skin - clammy when taking Plenvu? *

What are other drugs people take besides Plenvu? *

Vitamin D: 1 person, 9.09%
Evista: 1 person, 9.09%
Celecoxib: 1 person, 9.09%
Calcium: 1 person, 9.09%

What are other side effects people have besides Skin - clammy? *

Dizziness: 7 people, 63.64%
Nausea (feeling of having an urge to vomit): 7 people, 63.64%
Weakness: 6 people, 54.55%
Nausea And Vomiting: 6 people, 54.55%
Abdominal Pain: 6 people, 54.55%
Dyspnea (difficult or laboured breathing): 4 people, 36.36%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 36.36%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 36.36%
Loss Of Consciousness: 3 people, 27.27%
Head Injury: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Plenvu and have Skin - clammy?

- Check whether Skin - clammy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plenvu:

Plenvu (742 reports)

Skin - clammy treatments and more:

Skin - clammy (19,745 reports)

How severe was Skin - clammy and when was it recovered:

Skin - clammy in Plenvu

Expand to all the drugs that have ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate:

Skin - clammy and drugs with ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Plenvu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin - clammy:

Skin - clammy (1,125 drugs)

Browse all the conditions that are associated with Skin - clammy:

Skin - clammy (1,709 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Plenvu) and Plenvu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.